SEC Form 4 · accession 0001179110-15-011887
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey William Henderson
Director
Period of report
Aug 5, 2015
Accepted (ET)
Aug 7, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 5, 2015 | A | 6,405 | $0.00 | A | 6,405 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents initial restricted stock grant upon becoming a member of the Company's Board of Directors pursuant to the Director's Compensation Program. This grant will vest in 1/3rd increments on November 5, 2015, February 5, 2016 and the earlier of (i) the first anniversary of the grant date and (ii) the date of the Company's 2016 annual meeting of stockholders.